logo

Bonovo To Distribute Medical Devices For Elliquence In China
By: China Bio Today   Friday, October 23, 2009 1:36 PM

Vote for next session
The next market session will close:

Bonovo Orthopedics has struck a deal to distribute surgical procedure products for elliquence, LLC of New York State. Headquartered in the US, all of Bonovo's operations are in China. Bonovo manufactures orthopedic and neurosurgical products in its China facilities, and it also distributes other companies' medical devices through its China distribution network. Financial terms of the agreement were not announced.

elliquence's products are built around a patented Radiowave energy source, which uses high frequency, low temperature radiowaves to perform traditional scalpel, scissor, electrosurgical and laser-assisted procedures. According to elliquence, its tools have a cell-specific tissue effect, offering improved surgical precision while causing only minimal damage to healthy tissue. The low temperature emission results in non-adherent bipolar performance which minimizes tissue trauma and eliminates frequent cleaning and instrument irrigation.

Besides its minimally invasive surgical tool, elliquence also offers a product specifically aimed at minimally invasive discectomy procedures for contained lumbar spine herniations.

For its part, Bonovo was formed by merging two China companies: Beijing Orthopedic Innovations Inc. and Orthopedic International Trading (Shanghai) Inc. The company operates two factories in China, one in Shanghai, the other in Tianjin, which manufacture orthopedic products such as knee, hip and spine replacements that Bonovo sells in Asia. The company's goal is to make itself recognized in China as the highest quality provider of joint replacements.

Bonovo has 180 employees and over 30 products in its portfolio. Last year, it became the exclusive China distributor for Pioneer Surgical Technology Inc.'s spine products.


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Partner Center
Recent Articles by China Bio Today



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia